Sort
15,842 grants matching “pancreatic cancer”
Commercializing Praedicare Dx TM platform for guiding cancer treatments
$991,179Michael H Cardone · Eutropics Pharmaceuticals, Inc. · R44 · FY2018 · CA
Regulation of tumor suppression by alpha-ketoglutarate
$990,412Lydia Finley · Sloan-Kettering Inst Can Research · R37 · FY2025 · CA
Development of novel therapeutics for cancer cachexia
$990,411Scott Matthew Ebert · Emmyon, Inc. · R44 · FY2023 · CA
Development of a DCLK1 siRNA Nanoparticle as Targeted Therapy to Treat Pancreatic Cancer
$989,826Eliseu O. De Oliveira · Coare Holdings, Inc. · R44 · FY2021 · CA
Phase I Clinical Testing of a First-in-Class Therapy against Metastatic Cancer
$988,765Zdravka O. Medarova · Transcode Therapeutics, Inc. · R44 · FY2025 · CA
Development of a TRAIL-based therapy for alcohol related chronic pancreatitis
$988,751Victor V Roschke · Theraly Fibrosis, Inc. · U44 · FY2018 · AA
Molecular, Cellular, and Tissue Characterization Unit
$988,750William E Gillanders · Washington University · U2C · FY2021 · CA
PNNL Proteome Characterization Center
$987,941Tao Liu · Battelle Pacific Northwest Laboratories · U24 · FY2020 · CA
Selection and preclinical development of a bacteria-targeting, non-antibiotic lead candidate to improve cancer chemotherapy outcomes
$987,570Ward Peterson · Symberix, Inc. · R44 · FY2019 · CA
The role of stem cells and the microenvironment in gastrointestinal cancers
$987,000Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2023 · CA
Mesothelin-targeted immunotoxins in Pancreatic Cancer
$986,847Christine Alewine · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Identifying Metabolic Dependencies of Pancreatic Cancers
$986,490Alec Kimmelman · New York University School Of Medicine · R35 · FY2019 · CA
Development and Preclinical Applications of Pancreatic Adenocarcinoma Models
$986,350Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
The role of stem cells and the microenvironment in gastrointestinal cancers
$986,058Timothy Cragin Wang · Columbia University Health Sciences · R35 · FY2025 · CA
Interrogating the Evolutionary Dynamics of Cancer for Clinical Benefit and Actionability
$985,909Christine A Iacobuzio-Donahue · Sloan-Kettering Inst Can Research · R35 · FY2024 · CA
Mitigation of Radiation Induced Gastrointestinal Syndrome.
$985,537Andrew John Norris · Bcn Biosciences, Llc · R44 · FY2025 · AI
Elucidation and targeting of paracrine cascades in PDAC
$985,518Kenneth P Olive · Columbia University Health Sciences · U01 · FY2022 · CA
Elucidation and targeting of paracrine cascades in PDAC
$985,518Kenneth P Olive · Columbia University Health Sciences · U01 · FY2025 · CA
Elucidation and targeting of paracrine cascades in PDAC
$985,518Kenneth P Olive · Columbia University Health Sciences · U01 · FY2023 · CA
Stromal modulation of pancreatic cancer malignant cell state and therapeutic sensitivity
$985,172William C Hahn · Dana-Farber Cancer Inst · U01 · FY2024 · CA
High Cell Density Bioartificial Pancreas Enabled by Implantable Oxygen Generator
$984,736Linda A Tempelman · Giner, Inc. · R44 · FY2015 · DK
Biomolecular Recognition and Binding Mechanisms
$984,067Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Using markers to improve pancreatic cancer screening and surveillance
$983,899Michael G. Goggins · Johns Hopkins University · U01 · FY2016 · CA
Studies of Rare Cancers
$983,415Louise Brinton · Division Of Cancer Epidemiology And Genetics · Z01 · FY2008 · CA
Molecular Imaging and Theranostics of Cancer
$982,256Zaver M Bhujwalla · Johns Hopkins University · R35 · FY2021 · CA